GEN Exclusives

More »

GEN Exclusives

More »

For full access to this article login to GEN Select now.

May 6, 2014

Cancer Omics—How Much Information is Enough?

Knowledge is power, but is that knowledge always worth the cost?

Cancer Omics—How Much Information is Enough?

The 21-gene expression Oncotype DX assay was developed to estimate the benefit of adjuvant chemotherapy for hormone receptor–positive breast cancer. [©Tyler Olson/Fotolia]

  • All genomic evidence points to increasing complexity in analyzing cancers for molecular characterization to indicate an appropriate treatment course and determine prognosis. But while ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

    • Do not put any letters or characters here if you are not a spy program.
    •  

Get GEN Select Access Now



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

The Triple Package and Success

One theory for explaining “success," put forward by Amy Chua Jed Rubenfeld, posits cultural traits such as a superiority complex, personal insecurity and impulse control. Union College professors Joshua Hart and Christopher Chabris counter that intelligence, conscientiousness, and economic advantage are the most likely elements of success, regardless of ethnicity. Do you think that Hart-Chabris make a better argument for achieving success than the Chua-Rubenfeld theory?

More »